These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 14993750)

  • 1. Analysis of the release process of phenylpropanolamine hydrochloride from ethylcellulose matrix granules II. effects of the binder solution on the release process.
    Fukui A; Fujii R; Yonezawa Y; Sunada H
    Chem Pharm Bull (Tokyo); 2004 Mar; 52(3):298-302. PubMed ID: 14993750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the release process of phenylpropanolamine hydrochloride from ethylcellulose matrix granules.
    Fukui A; Fujii R; Yonezawa Y; Sunada H
    Chem Pharm Bull (Tokyo); 2002 Nov; 50(11):1439-42. PubMed ID: 12419906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the release process of phenylpropanolamine hydrochloride from ethylcellulose matrix granules IV.(1)) Evaluation of the controlled release properties for in vivo and in vitro release systems.
    Fukui A; Fujii R; Yonezawa Y; Sunada H
    Chem Pharm Bull (Tokyo); 2007 Nov; 55(11):1569-73. PubMed ID: 17978513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the release process of phenylpropanolamine hydrochloride from ethylcellulose matrix granules V. Release properties of ethylcellulose layered matrix granules.
    Fukui A; Fujii R; Yonezawa Y; Sunada H
    Chem Pharm Bull (Tokyo); 2008 Apr; 56(4):525-9. PubMed ID: 18379102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the release process of phenylpropanolamine hydrochloride from ethylcellulose matrix granules III. Effects of the dissolution condition on the release process.
    Fukui A; Fujii R; Yonezawa Y; Sunada H
    Chem Pharm Bull (Tokyo); 2006 Aug; 54(8):1091-6. PubMed ID: 16880650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fabrication of multiunit controlled-release phenylpropanolamine hydrochloride tablets.
    Mitrevej A; Sinchaipanid N; Natpoolwat N; Naratikornrit N
    Drug Dev Ind Pharm; 1998 Aug; 24(8):793-6. PubMed ID: 9876528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained-release dosage form of phenylpropanolamine hydrochloride. Part I: Microencapsulation and in vitro release kinetics.
    Sevgi F; Ozyazici M; Güneri T
    J Microencapsul; 1994; 11(3):327-34. PubMed ID: 8064556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained-release dosage form of phenylpropanolamine hydrochloride. Part II: Formulation and in vitro release kinetics from tableted microcapsules.
    Sevgi F; Ozyazici M; Güneri T
    J Microencapsul; 1994; 11(3):335-44. PubMed ID: 8064557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled release of radioprotective agents from matrix tablets--effect of preparative conditions on release rates.
    Benita S; Shani J; Abdulrazik M; Samuni A
    J Pharm Pharmacol; 1984 Apr; 36(4):222-8. PubMed ID: 6144767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wet granulation fine particle ethylcellulose tablets: effect of production variables and mathematical modeling of drug release.
    Agrawal AM; Neau SH; Bonate PL
    AAPS PharmSci; 2003; 5(2):E13. PubMed ID: 12866940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examination of aqueous oxidized cellulose dispersions as a potential drug carrier. II. In vitro and in vivo evaluation of phenylpropanolamine release from microparticles and pellets.
    Zhu L; Kumar V; Banker GS
    AAPS PharmSciTech; 2004 Aug; 5(4):e70. PubMed ID: 15760067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An innovative matrix controlling drug delivery produced by thermal treatment of DC tablets containing polycarbophil and ethylcellulose.
    Caviglioli G; Baldassari S; Cirrincione P; Russo E; Parodi B; Gatti P; Drava G
    Int J Pharm; 2013 Dec; 458(1):74-82. PubMed ID: 24144954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of the solid dispersion method to the controlled release of medicine. IV. Precise control of the release rate of a water soluble medicine by using the solid dispersion method applying the difference in the molecular weight of a polymer.
    Yuasa H; Ozeki T; Kanaya Y; Oishi K
    Chem Pharm Bull (Tokyo); 1993 May; 41(5):933-6. PubMed ID: 8339340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained-release and swelling characteristics of xanthan gum/ethylcellulose-based injection moulded matrix tablets: in vitro and in vivo evaluation.
    Quinten T; De Beer T; Onofre FO; Mendez-Montealvo G; Wang YJ; Remon JP; Vervaet C
    J Pharm Sci; 2011 Jul; 100(7):2858-70. PubMed ID: 21254067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained-release phenylpropanolamine hydrochloride bilayer caplets containing the hydroxypropylmethylcellulose 2208 matrix. II. Effects of filling order in bilayer compression and manufacturing method of the prolonged-release layer on compactibility of bilayer caplets.
    Ohmori S; Makino T
    Chem Pharm Bull (Tokyo); 2000 May; 48(5):678-82. PubMed ID: 10823706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of polyvinylpyrrolidone both as a binder and pore-former on the release of sparingly water-soluble topiramate from ethylcellulose coated pellets.
    Yang M; Xie S; Li Q; Wang Y; Chang X; Shan L; Sun L; Huang X; Gao C
    Int J Pharm; 2014 Apr; 465(1-2):187-96. PubMed ID: 24530810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained release phenylpropanolamine hydrochloride from ATO 888 matrix.
    Perez MA; Ghaly ES; Marti A
    P R Health Sci J; 1993 Dec; 12(4):263-7. PubMed ID: 8140204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of spray-dried chitosan acetate and ethylcellulose as compression coats for colonic drug delivery: effect of swelling on triggering in vitro drug release.
    Nunthanid J; Luangtana-anan M; Sriamornsak P; Limmatvapirat S; Huanbutta K; Puttipipatkhachorn S
    Eur J Pharm Biopharm; 2009 Feb; 71(2):356-61. PubMed ID: 18762255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained-release phenylpropanolamine hydrochloride bilayer caplets containing the hydroxypropylmethylcellulose 2208 matrix. I. Formulation and dissolution characteristics.
    Ohmori S; Makino T
    Chem Pharm Bull (Tokyo); 2000 May; 48(5):673-7. PubMed ID: 10823705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of extended-release solid dispersion granules of tacrolimus: evaluation of release mechanism and human oral bioavailability.
    Tsunashima D; Yamashita K; Ogawara KI; Sako K; Hakomori T; Higaki K
    J Pharm Pharmacol; 2017 Dec; 69(12):1697-1706. PubMed ID: 28872687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.